MPM BioImpact’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-614,010	Closed	-$10.8M	–	47
2024 Q1	$10.8M	Buy	614,010 +514,010	+514%	+$9M	1.73%	22
2023 Q4	$2.18M	Sell	100,000 -155,323	-61%	-$3.38M	0.51%	30
2023 Q3	$3.92M	Hold	255,323	–	–	1.05%	28
2023 Q2	$6.07M	Buy	+255,323	New	+$6.07M	1.22%	26